Clinical complete response to serplulimab plus bevacizumab and chemotherapy in MSS/KRAS-mutant metastatic sigmoid colon adenocarcinoma: a case report and literature review
Mismatched-repair–proficient/microsatellite-stable (pMMR/MSS) metastatic colorectal cancer (mCRC) is typically refractory to immune checkpoint inhibitors. Early randomized data suggest that adding PD-1 blockade to anti-angiogenic therapy and oxaliplatin-based chemotherapy may improve outcomes, but r...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-07-01
|
| Colección: | Frontiers in Immunology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1740803/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|